RRA-19284 Survey of the Effectiveness of the DARZALEX® Educational Materials Regarding the Minimization of Risk of Interference for Blood Typing with Daratumumab First published 02/08/2017 Last updated 11/12/2019 EU PAS number:EUPAS20119 Study Finalised